Immune activation markers associated with levels and diversity of intact HIV proviruses during HIV- HBV co-infection

• X.Q. Wang,
• B. Horsburgh,
• K. Fisher,
• J. Zerbato,
• J. Audsley,
• A. Avihingsanon,
• A. Rhodes,
• J. Stout,
• S. Lewin,
• S. Palmer

Affiliations

X.Q. Wang

Westmead Institute for Medical Research, Westmead, NSW, Australia; Sydney Medical School-Westmead, University of Sydney, Westmead, NSW, Australia

B. Horsburgh

Westmead Institute for Medical Research, Westmead, NSW, Australia; Sydney Medical School-Westmead, University of Sydney, Westmead, NSW, Australia

K. Fisher

Westmead Institute for Medical Research, Westmead, NSW, Australia

J. Zerbato

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia

J. Audsley

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia

A. Avihingsanon

HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand

A. Rhodes

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia

J. Stout

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia

S. Lewin

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Victoria, Australia

S. Palmer

Westmead Institute for Medical Research, Westmead, NSW, Australia; Sydney Medical School-Westmead, University of Sydney, Westmead, NSW, Australia